Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

ErbB3 program development candidate selection triggers $5M milestone payment to AVEO Pharmaceuticals

AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced it has received a $5 million milestone payment from Biogen Idec International GmbH, a subsidiary of Biogen Idec, Inc., for the selection of the first humanized antibody development candidate from its ErbB3 program.

15 Apr 2010

FDA approves J&JPRD's PANCREAZE NDA

Johnson & Johnson Pharmaceutical Research and Development (J&JPRD) announced that the U.S. Food and Drug Administration (FDA) has approved a new drug application (NDA) for PANCREAZE™ (pancrelipase) delayed-release capsules for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis or other conditions. Exocrine pancreatic insufficiency is the inability to properly digest and absorb food due to a lack of enzymes made by the pancreas that are important in the digestion of fats, proteins, and sugars.

15 Apr 2010

Australian scientists sequence genome of pancreatic cancer

The International Cancer Genome Consortium which includes researchers from 22 countries is mapping the genomes of different types of cancers. A genome is essentially a blueprint of a human’s DNA. The genetic data of each individual is different and so is the genetic data of the cancer in the individual. The Australian scientists are sequencing the genomes of people suffering from pancreatic cancer.

15 Apr 2010

Noncompetitive ''win-win'' relationship between gynecologist and radiologist benefits patients

Journal of Minimally Invasive Gynecology (JMIG) has published a study in its March/April issue which concluded that establishing a referral relationship with an interventional radiologist for comprehensive uterine myoma (fibroid) treatment supports a trusting, collaborative, long-term, noncompetitive ''win-win'' relationship between the gynecologist and radiologist.

13 Apr 2010

Mersana Therapeutics, Teva Pharmaceutical Industries sign research and license agreement

Mersana Therapeutics, a platform-based cancer therapeutics company, today announced that it has entered into a research and exclusive license agreement with Teva Pharmaceutical Industries Ltd. to develop and commercialize XMT-1107, a novel fumagillin analog, for the treatment of all indications, including cancer.

13 Apr 2010

AACR Annual Meeting 2010: Æterna Zentaris to present data on Erk/PI3K inhibitor compounds

Æterna Zentaris Inc. a late-stage drug development company specialized in oncology and endocrinology, today announced that it will make an oral presentation, as well as a poster presentation on Erk/PI3K inhibitor compounds, Tuesday, April 20, at the American Association for Cancer Research (AACR) Annual Meeting, to be held April 17-21, 2010 at the Walter E. Washington Convention Center in Washington, D.C.

13 Apr 2010

EntreMed commences Phase 2 study of ENMD-2076 for platinum resistant ovarian cancer

EntreMed, Inc. today announced the initiation of a multi-center Phase 2 study with its lead oncology product candidate, ENMD-2076, in patients with platinum resistant ovarian cancer. The study will be conducted at up to six sites in the United States and Canada. In addition, EntreMed received a No Objection Letter (NOL) from the Therapeutic Products Directorate of Health Canada on its Clinical Trial Application to conduct the Phase 2 clinical trial in ovarian cancer patients.

13 Apr 2010

Perceptive Informatics expands medical imaging capabilities with enhanced reporting solution

Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation, today announced that it has expanded its leading medical imaging capabilities with an enhanced reporting solution.

From Parexel 13 Apr 2010

Hospital quality needs significant improvement: 2009 Leapfrog Hospital Survey

According to new results from the 2009 Leapfrog Hospital Survey released today at the World Health Congress in Washington, DC, hospital quality needs significant improvement and waste remains rampant. One encouraging sign: steady improvements over time, supporting the value of hundreds of purchasers' growing efforts to use Leapfrog performance data in decision-making, contracting, pay for performance, and benefits design.

13 Apr 2010

AVEO Pharmaceuticals to present preclinical data from translational research platform at AACR 2010

AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that preclinical data from its translational research platform and antibody pipeline will be presented during six poster sessions at the American Association for Cancer Research 101st Annual Meeting 2010 being held April 17-21, 2010, in Washington, D.C.

13 Apr 2010

Delcath's Phase III PHP-mel trial data accepted for presentation at ASCO's 2010 Annual Meeting

Delcath Systems, Inc., a medical technology company testing its proprietary treatment system for primary and metastatic cancers to the liver, announced today that the American Society of Clinical Oncology (ASCO) has accepted an abstract for oral presentation of Delcath's Phase III Trial Data comparing percutaneous hepatic perfusion with melphalan (PHP-mel) to the best alternative care for patients with hepatic metastases from ocular or cutaneous melanoma for ASCO's 2010 Annual Meeting, to be held June 4-8, 2010 at McCormick Place in Chicago.

13 Apr 2010

Health care professionals urge Congress to support nation's chemical regulatory reform

On the eve of legislation slated to be introduced this month to reform the Toxic Substances Control Act, almost two dozen organizations representing health care professionals, along with health sector businesses sent letters to Congress urging the passage of strong reform of our nation's chemical regulatory system.

13 Apr 2010

American Lung Association's report examines lung cancer among African Americans

The American Lung Association today released its report, Too Many Cases, Too Many Deaths: Lung Cancer in African Americans, a compilation of research examining lung cancer among African Americans and the need to eliminate this and other health disparities.

13 Apr 2010

TD2, Horizon Discovery announce strategic alliance to advance personalized medicine

A strategic alliance announced today between TGen Drug Development (TD2) and Horizon Discovery Limited will significant advance personalized medicine.

13 Apr 2010

Silence Therapeutics reorganizes resources following Intradigm merger

Silence Therapeutics plc announces that the Company is executing a strategic plan designed to optimally organize its resources following its recent merger with Intradigm Corporation. Moving forward, all research activities related to Silence's novel RNA interference (RNAi) therapeutic platforms, including technologies that have emerged from both Silence and Intradigm, will take place at the Company's Berlin location.

13 Apr 2010

First direct recording of mirror neurons in the brain

Mirror neurons, many say, are what make us human. They are the cells in the brain that fire not only when we perform a particular action but also when we watch someone else perform that same action.

13 Apr 2010

Camp Okizu's brain tumor weekend program has new benefactor

Camp Okizu, a non-profit camp in northern California for kids with cancer and their families, has a new benefactor for its weekend program for families of children with brain tumors. In honor of Silicon Valley executive James W. Hebert, who died from a brain tumor at age 54 in 2006, his wife, Ronni Sarmanian, also a former tech executive, has committed to sponsor the event. This annual event, which will be called the James W. Hebert Family Camp, begins April 16 and coincides with Hebert's birthday, April 13.

13 Apr 2010

Oncology News and Research

Further Reading

ErbB3 program development candidate selection triggers $5M milestone payment to AVEO Pharmaceuticals

FDA approves J&JPRD's PANCREAZE NDA

Australian scientists sequence genome of pancreatic cancer

Noncompetitive ''win-win'' relationship between gynecologist and radiologist benefits patients

Mersana Therapeutics, Teva Pharmaceutical Industries sign research and license agreement

AACR Annual Meeting 2010: Æterna Zentaris to present data on Erk/PI3K inhibitor compounds

EntreMed commences Phase 2 study of ENMD-2076 for platinum resistant ovarian cancer

Perceptive Informatics expands medical imaging capabilities with enhanced reporting solution

Hospital quality needs significant improvement: 2009 Leapfrog Hospital Survey

AVEO Pharmaceuticals to present preclinical data from translational research platform at AACR 2010

Delcath's Phase III PHP-mel trial data accepted for presentation at ASCO's 2010 Annual Meeting

Health care professionals urge Congress to support nation's chemical regulatory reform

American Lung Association's report examines lung cancer among African Americans

TD2, Horizon Discovery announce strategic alliance to advance personalized medicine

Silence Therapeutics reorganizes resources following Intradigm merger

First direct recording of mirror neurons in the brain

Camp Okizu's brain tumor weekend program has new benefactor

Cancer drug, antiviral agent can eradicate active virus infection and tumor: UNC School of Medicine

Javelin Pharmaceuticals intends to terminate Merger Agreement with Myriad Pharmaceuticals

Common drug used to treat Burkitt lymphoma can activate EBV: Study

Event guide: 10th CAR-TCR Summit eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News